VF
ALZN icon

Virtu Financial’s Alzamend Neuro ALZN Stock Holding History

Virtu Financial’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,582
Closed -$23K – 1590
2025
Q4 		$23K Buy
+12,582
New +$28.5K ﹤0.01% 1400
2025
Q1 		– Sell
-1,413
Closed -$15K – 1315
2024
Q4 		$15K Buy
+1,413
New +$18.2K ﹤0.01% 1339
2024
Q2 		– Sell
-294
Closed -$26K – 1262
2024
Q1 		$26K Buy
+294
New +$25.2K ﹤0.01% 1131
2023
Q3 		– Sell
-16
Closed -$11K – 1254
2023
Q2 		$11K Sell
16
-34
-68% -$26.6K ﹤0.01% 1338
2023
Q1 		$29K Buy
50
+4
+9% +$3.01K ﹤0.01% 1173
2022
Q4 		$35K Buy
+46
New +$66.6K ﹤0.01% 1150
2022
Q1 		– Sell
-17
Closed -$44K – 1462
2021
Q4 		$44K Buy
+17
New +$52.6K ﹤0.01% 1367
2021
Q3 		– Sell
-11
Closed -$135K – 1459
2021
Q2 		$135K Buy
+11
New +$142K 0.01% 1123

Other funds holding ALZN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Virtu Financial's ALZN Position: Q1 2026 in Review

Virtu Financial sold out of Alzamend Neuro (ALZN) in Q1 2026, closing a stake of 12,582 shares — an estimated $23K sold.

Virtu Financial first reported a position in ALZN in Q2 2021 and held it in 8 quarters. The position peaked at $135K in Q2 2021. 12 funds tracked by Wall St. Rank hold ALZN as of Q1 2026.

  • Virtu Financial reported no remaining Alzamend Neuro position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 12,582 Alzamend Neuro shares in Q1 2026, an estimated $23K.
  • Virtu Financial first reported a position in Alzamend Neuro in Q2 2021 and held it in 8 quarters.
  • Virtu Financial's Alzamend Neuro position peaked at $135K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Alzamend Neuro as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.